Microbiological features of the indicators of bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) during remission

M. Smirnova-Saprytskaya (??????, Russian Federation), G. Osipova (??????, Russian Federation), T. Ospelnikova (??????, Russian Federation), G. Danilina (??????, Russian Federation), K. Zykov (??????, Russian Federation)

Source: International Congress 2019 – Clinical aspects of airway diseases
Session: Clinical aspects of airway diseases
Session type: Thematic Poster
Number: 2761
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Smirnova-Saprytskaya (??????, Russian Federation), G. Osipova (??????, Russian Federation), T. Ospelnikova (??????, Russian Federation), G. Danilina (??????, Russian Federation), K. Zykov (??????, Russian Federation). Microbiological features of the indicators of bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) during remission. 2761

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018


The relationship between fibroblasts and airway structure in patients with asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 148s
Year: 2001

The respiratory microbiome in chronic obstructive pulmonary disease (COPD) exacerbations: Relationships with clinical characteristics
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012

Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 521s
Year: 2004

Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008


The state of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 547s
Year: 2007

Longitudinal study of FEO1 as a criterion for bronchial obstruction in outpatients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 64s
Year: 2005

Large airways remodeling in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2008 - Pathophysiology of respiratory diseases
Year: 2008


Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020


Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005

Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
Source: Guideline 1995
Year: 1995

Pulmonary rehabilitation (PR) outcomes in chronic obstructive pulmonary disease (COPD) compared with interstitial lung disease (ILD)
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011

Seasonal variations and outcomes in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - The nursing challenges and strategies when caring for patients with chronic lung disease
Year: 2010

Early phenotypes of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Different data in COPD
Year: 2015

Can chronic obstructive lung disease (COPD) criteria be used to manage bronchiectasis (BR) and obliterative bronchiolitis (OB) in children surviving severe lung infection?
Source: Eur Respir J 2001; 18: Suppl. 33, 172s
Year: 2001

Awareness of chronic obstructive pulmonary disease (COPD) in Portugal
Source: Eur Respir J 2007; 30: Suppl. 51, 126s
Year: 2007

Upper airway symptoms and quality of life in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 540s
Year: 2003

Prevalence of chronic rhinosinusitis in COPD stable patients
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006